tolvaptan has been researched along with Inappropriate ADH Syndrome in 121 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (9.92) | 29.6817 |
| 2010's | 90 (74.38) | 24.3611 |
| 2020's | 19 (15.70) | 2.80 |
| Authors | Studies |
|---|---|
| Estilo, A; McCormick, L; Rahman, M | 1 |
| Kimura, Y; Kusumi, F; Matsumoto, A; Matsuyama, S; Minami, R; Ohana, M; Okano, A; Ozawa, T; Takeda, Y; Ueo, T | 1 |
| Gosch, M | 1 |
| Gannamani, V; Nathan, S; Ustun, C; Varma, A | 1 |
| Barajas Galindo, DE; de la Vega, IR; Fernández Martínez, A; Ferrer García, JC; Gómez Hoyos, E; Ortolá Buigues, A; Ropero-Luis, G; Ruiz-Sánchez, JG; Serrano Gotarredona, J | 1 |
| Adamo, V; Campo, S; Lacquaniti, A; Monardo, P; Russo, A | 1 |
| Bird-Lieberman, G; Bockenhauer, D; Gilbert, RD; Hoogenboom, L; Kumaran, A; Moon, RJ; Singh, J; Soliman, M | 1 |
| Gärtner, F; Jansen, O; Laudes, M; Reinke, LM; Rohmann, N; Schreiber, S; Schulte, DM; Seoudy, AK | 1 |
| Alexandrou, D; Amin, R; Bockenhauer, D; Dattani, M; Famuboni, A; Gan, HW; Lopez-Garcia, C; Shah, S; Trompeter, R; Veligratli, F | 1 |
| Aliberti, L; Ambrosio, MR; Bondanelli, M; Gagliardi, I; Zatelli, MC | 1 |
| Baba, K; Horikirizono, H; Igase, M; Kambayashi, S; Kimura, K; Mizuno, T; Okuda, M; Tamura, Y; Yamamoto, H | 1 |
| Chen, S; Ke, X; Li, J; Miao, H; Pan, H; Yuan, X; Zhu, H | 1 |
| Gwak, HS; Kim, Y; Lee, KE; Lee, N | 1 |
| Jhaveri, KD; Rondon-Berrios, H; Workeneh, BT | 1 |
| Flägel, K; Gosch, M; Hofmann, W | 1 |
| Arima, H; Goto, K; Hirano, T; Ishikawa, SE; Motozawa, T; Mouri, M; Watanabe, R | 1 |
| Basal, FB; Bilgetekin, I; Demirci, U; Erturk, I; Karacin, C; Karadurmus, N; Oksuzoglu, B | 1 |
| B, N; Jayadeep, S; Khan, MF; Pai, K; Varma, M; Vidyasagar, S | 1 |
| de Jong-Laird, A; Kabra, M; Lindner, U; Pose-Reino, A; Runkle de la Vega, I | 1 |
| Bonny, O; Martin, PY; Stucker, F | 1 |
| Di Mise, A; Geller, A; Ranieri, M; Tamma, G; Tamma, R; Valenti, G; Zallone, A | 1 |
| Boklage, S; Kamat, S; Mladsi, D; Ramamohan, V; Ronquest, N | 1 |
| De Sanctis, L; Einaudi, S; Matarazzo, P; Tessaris, D; Tuli, G | 1 |
| Grassi, P; Peverelli, G | 1 |
| Bricmont, P; Dandurand, A; Shoaf, SE | 1 |
| Garrahy, A; Hannon, AM; Thompson, CJ; Williams, DJ; Zia-Ul-Hussnain, HM | 1 |
| Kinugawa, K; Kugai, T; Nakamura, M; Sunagawa, O | 1 |
| Antonuzzo, A; Berardi, R; Blasi, L; Buosi, R; Lorusso, V; Migliorino, MR; Montesarchio, V; Peri, A; Sabbatini, R; Zilembo, N | 1 |
| Bhasin, B; Bohm, NM; Crawford, R; Kelley, D; Morris, JH; Nemecek, BD; Nietert, PJ; Velez, JCQ | 1 |
| Choi, HY; Ha, SK; Han, SW; Jeong, KH; Kang, KP; Kim, GH; Kim, HJ; Kim, HY; Kim, SW; Kim, YW; Shin, SK; Yi, JH | 1 |
| Sterns, RH | 1 |
| Foppiani, L | 1 |
| Gürbüz, F; Taştan, M; Turan, İ; Yüksel, B | 1 |
| Peri, A | 2 |
| Ichikawa, D; Kai, K; Koitabashi, K; Shibagaki, Y; Tominaga, N | 1 |
| Kitchlu, A; Rosner, MH | 1 |
| Behr, J; Dietrich, JW; Heyer, CM; Knoop, H; Knoop, U; Kuert, S; Roggenland, D; Suermann, M | 1 |
| Angelini, C; Arosio, P; Bertuzzi, A; Colombo, P; Cucchiari, D; De Sanctis, R; Faucher, E; Fusco, N; Pellegrinelli, A | 1 |
| Benso, A; Brandolin, I; Foppiani, L; Lo Pinto, G; Raggi, F; Tagliabue, M | 1 |
| Aghi, MK; Blevins, L; Jahangiri, A; Kunwar, S; Miller, LM; Tom, MW; Tran, MT; Wagner, J | 1 |
| Grohé, C; Lüders, H; Petereit, C; Teber, I; Zaba, O | 1 |
| Formiga, F; Navarro, A; Poch, E; Pose, A; Runkle, I; Tejedor, A; Villabona, C | 2 |
| Kilonzo, K; Lee, JJ; Nistico, A; Yeates, K | 1 |
| Aberle, J; Burkhardt, T; Flitsch, J; Janneck, M; Rotermund, R; Sauer, N | 1 |
| Giuliani, C; Peri, A | 1 |
| Aoki, A; Asano, T; Ikoma, A; Ishikawa, SE; Kakei, M; Kusaka, I; Yamada, H; Yamashita, T; Yoshida, M | 1 |
| Berlit, P; Kraayvanger, L; Latza, J; Vockelmann, C; Weber, R | 1 |
| Chen, S; Gu, F; Guo, XH; Liu, ZM; Ma, JH; Qiu, MC; Tong, NW; Yang, GY; Zhang, ZW; Zhao, JJ | 1 |
| Adhiyaman, V; Chattopadhyay, I; Williams, M | 1 |
| Alioto, D; Alonso Pérez, L; Cañamares Orbis, I; Ferrari Piquero, JM; Gómez Valbuena, I | 1 |
| Hiddemann, W; Schnaiter, A | 1 |
| Haas, CS | 1 |
| Fernández Catalina, P; Lorenzo Solar, M; Rego Iraeta, A; Sánchez Sobrino, P | 1 |
| Ardizzoni, A; Bordi, P; Buti, S; Regolisti, G; Tiseo, M | 1 |
| Lindner, U; Schäffler, A | 1 |
| Acaban, MB; Arı, H; Kahraman, F | 1 |
| Ayuk, J; Bouloux, PM; Cohen, M; Cranston, I; Grant, P; Grossman, A; Murray, RD; Rees, A; Thatcher, N | 1 |
| Blau, W; Brock, J; Gattenlöhner, S; Karrasch, T; Nilles, M; Roller, FC; Roller, FF; Schäffler, A; Steiner, D | 1 |
| Balla, A; Erdélyi, LS; Groß, U; Hunyady, L; Mann, WA; Morris-Rosendahl, DJ; Nagel, M; Várnai, P | 1 |
| Aylwin, S; Burst, V; Peri, A; Runkle, I; Thatcher, N | 1 |
| Bagkeris, E; Bouloux, PM; Carr, H; Cohen, M; Khoo, B; Tzoulis, P; Waung, JA | 1 |
| Camps Herrero, C; Carcereny, E; De Las Peñas, R; Escobar Álvarez, Y; Henao, F; López López, R; Ponce, S; Rodríguez, CA; Virizuela, JA | 1 |
| Mali, P; Muduganti, SR; Mujibur, R; Murali, N | 1 |
| Haas, CS; Harbeck, B; Lindner, U | 1 |
| Bandhakavi, M; Bockenhauer, D; Dattani, M; Kleta, R; Marx-Berger, D; Milford, DV; Van't Hoff, W | 1 |
| Gisby, M; Jamookeeah, C; Ländin, M; Lundberg, J; O'Reilly, K; Robinson, P; Skov, J; Trueman, D | 1 |
| Bagkeris, E; Bouloux, PM; Carr, H; Tzoulis, P | 1 |
| Bockenhauer, D; Booth, C; Carroll, A; Dufek, S; Kleta, R; Van't Hoff, W | 1 |
| Llompart-Pou, JA; Novo, M; Pérez-Bárcena, J; Raurich, JM | 1 |
| Tesař, V | 1 |
| Ahmad, F; Blais, JD; Chiodo, J; Czerwiec, FS; Glaser, LA; Gralla, RJ; Zhou, W | 1 |
| Jung, MC; Kim, HJ; Kim, JK; Kim, SG; Lee, CM; Park, GH; Song, JW; Song, YR | 1 |
| Laczi, F | 1 |
| Goldsmith, SR | 2 |
| Audino, B; Curtis, J; Filmyer, DM; Josiassen, RC; Shaughnessy, RA; Skuban, N | 1 |
| Sherlock, M; Thompson, CJ | 1 |
| Carluccio, AL; Merlin, MA; Zenenberg, RD | 1 |
| Hutchinson, DJ; Nemerovski, C | 1 |
| Hensen, J | 3 |
| Villabona, C | 1 |
| Elhassan, EA; Schrier, RW | 1 |
| Adler, S; Berl, T; Czerwiec, FS; Schrier, RW; Verbalis, JG; Zhao, Q | 1 |
| Er, F; Fuhr, U; Gassanov, N; Nia, AM; Semmo, M; Semmo, N | 1 |
| Decaux, G; Gross, PA; Wagner, A | 1 |
| Pinal-Fernández, I; Segura-García, A | 1 |
| DeVita, MV; Michelis, MF; Vaghasiya, RP | 1 |
| Cohen, AF; Dubois, EA; Rissmann, R | 1 |
| Benzing, T; Gross, P; Hensen, J; Mönig, H | 1 |
| Bohnet, S; Brabant, G; Haas, CS; Kenz, S; Werth, SC | 1 |
| Gargani, L; Gheorghiade, M; Schmidt, PH | 1 |
| Kettritz, R; Luft, FC | 1 |
| Angelini, C; Aroldi, A; Cucchiari, D; Gaetani, P; Graziani, G; Selmi, C | 1 |
| Caimi, G; Urso, C | 1 |
| Coffernils, M; Couturier, B; Decaux, G; Gankam-Kengne, F; Soupart, A | 1 |
| Chiong, JR; Christian, R; Dasta, JF; Lin, J | 1 |
| Combe, C; Peri, A | 1 |
| Bouloux, PM; Burst, V; Hoorn, EJ | 1 |
| Frøkjær, J; Jørgensen, JO; Rittig, S; Trolle, C | 1 |
| Bichet, DG | 1 |
| Decaux, G | 1 |
| Frank, D; Janssens, U; Meyer, I | 1 |
| Ring, T | 1 |
| Castillo, JJ; Justice, E; Vincent, M | 1 |
| Grossman, AB; Kar, P; Rajendran, R | 1 |
| Streefkerk, JO; van Zwieten, PA | 1 |
| Gross, P; Herbrig, K; Palm, C; Pistrosch, F | 1 |
| Berl, T; Czerwiec, FS; Gheorghiade, M; Gross, P; Orlandi, C; Schrier, RW; Verbalis, JG | 1 |
| Bouko, Y; Decaux, G; Parma, J; Vandergheynst, F; Vassart, G; Vilain, C | 1 |
| Hood, VL; Rimmer, JM; Weise, WJ | 1 |
| Hoorn, EJ; Zietse, R | 1 |
| Arici, M; Kirkpantur, A; Ozkan, C | 1 |
| Ali, F; Ghali, JK; Guglin, M; Vaitkevicius, P | 1 |
| Głuszek, J; Olszewski, W | 1 |
36 review(s) available for tolvaptan and Inappropriate ADH Syndrome
| Article | Year |
|---|---|
Tolvaptan and urea in paediatric hyponatraemia.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Child; Humans; Hyponatremia; Inappropriate ADH Syndrome; Sodium; Tolvaptan; Treatment Outcome; Urea | 2024 |
Hyponatremia in the cancer patient.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Humans; Hyponatremia; Inappropriate ADH Syndrome; Neoplasms; Quality of Life; Tolvaptan | 2020 |
[Clinical use of tolvaptan: a 2021 review].
Topics: Disease Progression; Drug-Related Side Effects and Adverse Reactions; Humans; Hyponatremia; Inappropriate ADH Syndrome; Tolvaptan | 2021 |
Tolvaptan Treatment in Children with Chronic Hyponatremia due to Inappropriate Antidiuretic Hormone Secretion: A Report of Three Cases
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Child; Child, Preschool; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Tolvaptan | 2017 |
Practical issues for the management of hyponatremia in oncology.
Topics: Antidiuretic Hormone Receptor Antagonists; Disease Management; Humans; Hyponatremia; Inappropriate ADH Syndrome; Neoplasms; Tolvaptan | 2018 |
Management of hyponatremia: causes, clinical aspects, differential diagnosis and treatment.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Awareness; Diagnosis, Differential; Electrolytes; Female; Gait; Health Status Disparities; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Models, Animal; Mutation; Rats; Receptors, Vasopressin; Tolvaptan | 2019 |
Hyponatremia in patients with cancer.
Topics: Fluid Therapy; Humans; Hyponatremia; Inappropriate ADH Syndrome; Neoplasms; Tolvaptan | 2019 |
Management of hyponatremia.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzamides; Benzazepines; Disease Management; Female; Humans; Hyponatremia; Hypovolemia; Inappropriate ADH Syndrome; Male; Morpholines; Prognosis; Pyrroles; Receptors, Vasopressin; Risk Assessment; Severity of Illness Index; Spiro Compounds; Tolvaptan; Treatment Outcome | 2014 |
Hyponatremia after trans-sphenoidal surgery.
Topics: Benzazepines; Humans; Hyponatremia; Hypophysectomy; Inappropriate ADH Syndrome; Pituitary Diseases; Pituitary Gland, Posterior; Postoperative Period; Prevalence; Saline Solution, Hypertonic; Sphenoid Bone; Tolvaptan | 2014 |
Management of euvolemic hyponatremia attributed to SIADH in the hospital setting.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Volume; Body Water; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Demeclocycline; Diabetes Insipidus, Nephrogenic; Disease Management; Drug Interactions; Hospitalization; Humans; Hydrocortisone; Hyponatremia; Hypothyroidism; Inappropriate ADH Syndrome; Kidney Tubules, Collecting; Lithium; Multicenter Studies as Topic; Osmolar Concentration; Paraneoplastic Syndromes; Saline Solution, Hypertonic; Tolvaptan | 2014 |
[Etiology, diagnostics and therapy of hyponatremias].
Topics: Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Blood Volume; Brain Diseases; Central Nervous System; Chronic Disease; Demeclocycline; Demyelinating Diseases; Diagnosis, Differential; Diuretics; Extracellular Fluid; Furosemide; Humans; Hyponatremia; Inappropriate ADH Syndrome; Lithium Compounds; Morpholines; Osmolar Concentration; Osmosis; Pyrroles; Severity of Illness Index; Sodium; Spiro Compounds; Time Factors; Tolvaptan; Vasopressins | 2008 |
Treatment options for hyponatremia in heart failure.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Pyrroles; Sodium Potassium Chloride Symporter Inhibitors; Tolvaptan; Treatment Outcome | 2009 |
Tolvaptan: a new tool for the effective treatment of hyponatremia in psychotic disorders.
Topics: Antidiuretic Hormone Receptor Antagonists; Antipsychotic Agents; Benzazepines; Comorbidity; Humans; Hyponatremia; Inappropriate ADH Syndrome; Prevalence; Psychotic Disorders; Tolvaptan | 2010 |
The syndrome of inappropriate antidiuretic hormone: current and future management options.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Clinical Trials as Topic; Disease Management; Forecasting; Humans; Hyponatremia; Inappropriate ADH Syndrome; Receptors, Vasopressin; Tolvaptan; Treatment Outcome | 2010 |
Tolvaptan (Samsca) for hyponatremia.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cardiomyopathy, Dilated; Clinical Trials as Topic; Drug Approval; Drug Interactions; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Osmolar Concentration; Tolvaptan; United States; United States Food and Drug Administration | 2009 |
Hyponatremia: evaluation and management.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Blood Urea Nitrogen; Cardiac Output, Low; Causality; Diagnosis, Differential; Glomerular Filtration Rate; Humans; Hyponatremia; Inappropriate ADH Syndrome; Kidney Tubules; Saline Solution, Hypertonic; Sodium; Tolvaptan; Uric Acid; Water-Electrolyte Balance | 2010 |
Treatment of hypervolemic or euvolemic hyponatremia associated with heart failure, cirrhosis, or the syndrome of inappropriate antidiuretic hormone with tolvaptan: a clinical review.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Volume; Dose-Response Relationship, Drug; Drug Interactions; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Randomized Controlled Trials as Topic; Sodium; Tolvaptan | 2010 |
Treatment options for hyponatremia in heart failure.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Biomarkers; Blood Volume; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Signal Transduction; Tolvaptan | 2010 |
[Treatment of hyponatremia: role of vaptans].
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Brain Edema; Humans; Hyponatremia; Inappropriate ADH Syndrome; Neurologic Examination; Risk Factors; Saline Solution, Hypertonic; Sodium; Tolvaptan; Water-Electrolyte Balance | 2010 |
[Vasopressin receptor antagonists: the vaptans].
Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Aquaporin 2; Benzamides; Benzazepines; Calcium Signaling; Clinical Trials as Topic; Cyclic AMP; Double-Blind Method; Drug Therapy, Combination; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Kidney Tubules, Collecting; Liver Cirrhosis; Morpholines; Multicenter Studies as Topic; Neoplasms; Pituitary Gland, Anterior; Pyrroles; Randomized Controlled Trials as Topic; Receptors, Vasopressin; Second Messenger Systems; Spiro Compounds; Tolvaptan; Vasopressins | 2010 |
Hyponatremia: diagnosis, complications, and management including V2 receptor antagonists.
Topics: Adaptation, Physiological; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Brain; Exercise; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Tolvaptan | 2011 |
Arginine vasopressin (AVP) and treatment with arginine vasopressin receptor antagonists (vaptans) in congestive heart failure, liver cirrhosis and syndrome of inappropriate antidiuretic hormone secretion (SIADH).
Topics: Antidiuretic Hormone Receptor Antagonists; Benzamides; Benzazepines; Diuretics; Heart Failure; Humans; Inappropriate ADH Syndrome; Liver Cirrhosis; Models, Biological; Morpholines; Pyrroles; Spiro Compounds; Tolvaptan; Water-Electrolyte Balance | 2011 |
Vaptans are not the mainstay of treatment in hyponatremia: perhaps not yet.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Drug Costs; Humans; Hyponatremia; Inappropriate ADH Syndrome; Tolvaptan | 2011 |
[Treatment of hyponatremia: new developments and controversies].
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Volume; Drinking; Humans; Hyponatremia; Inappropriate ADH Syndrome; Saline Solution, Hypertonic; Sodium; Sodium Chloride; Sodium Chloride Symporter Inhibitors; Tolvaptan; Urea | 2011 |
[Practical approach to hyponatremia].
Topics: Aged; Benzazepines; Carcinoma, Small Cell; Combined Modality Therapy; Critical Pathways; Diagnosis, Differential; Drinking; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Lung Neoplasms; Sodium; Tolvaptan | 2011 |
Tolvaptan for the treatment of hyponatremia secondary to the syndrome of inappropriate antidiuretic hormone secretion.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Hormone Antagonists; Humans; Hyponatremia; Inappropriate ADH Syndrome; Severity of Illness Index; Tolvaptan | 2011 |
[Disorders of fluid and electrolyte balance].
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Deamino Arginine Vasopressin; Humans; Hyperkalemia; Hypernatremia; Hyponatremia; Inappropriate ADH Syndrome; Membrane Potentials; Morpholines; Osmolar Concentration; Potassium; Randomized Controlled Trials as Topic; Sodium; Spiro Compounds; Survival Rate; Tolvaptan; Water-Electrolyte Imbalance | 2011 |
[Hyponatremic syndrome].
Topics: Aging; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Brain; Brain Edema; Exercise; Humans; Hyponatremia; Inappropriate ADH Syndrome; Infections; Inflammation; Kidney; Natriuresis; Neoplasms; Osmotic Pressure; Renal Replacement Therapy; Sodium; Tolvaptan; Water Intoxication | 2012 |
[SIADH and vaptans].
Topics: Anti-Bacterial Agents; Antidiuretic Hormone Receptor Antagonists; Antipsychotic Agents; Benzazepines; Demeclocycline; Hormone Antagonists; Humans; Inappropriate ADH Syndrome; Lithium; Models, Biological; Tolvaptan | 2012 |
Diagnosis and management of hyponatremia in cancer patients.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Disease Management; Humans; Hyponatremia; Hypovolemia; Inappropriate ADH Syndrome; Neoplasms; Receptors, Vasopressin; Risk Factors; Sodium; Tolvaptan | 2012 |
[Hyponatremia : The water-intolerant patient].
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Brain Edema; Chronic Disease; Diagnosis, Differential; Hyponatremia; Inappropriate ADH Syndrome; Infusions, Intravenous; Intensive Care Units; Neurologic Examination; Prognosis; Risk Factors; Saline Solution, Hypertonic; Survival Analysis; Tolvaptan | 2012 |
Clinical review: the use of vaptans in clinical endocrinology.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Clinical Trials as Topic; Drug Discovery; Endocrinology; Hormone Antagonists; Humans; Hyponatremia; Inappropriate ADH Syndrome; Models, Biological; Tolvaptan | 2013 |
Vasopressin receptor antagonists: pharmacological tools and potential therapeutic agents.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Drug Design; Heart Failure; Hormone Antagonists; Humans; Hypertension; Inappropriate ADH Syndrome; Indoles; Presynaptic Terminals; Pyrrolidines; Receptors, Vasopressin; Renal Artery; Sympathetic Nervous System; Synaptic Transmission; Tolvaptan; Vasoconstriction; Vasoconstrictor Agents | 2006 |
Vasopressin antagonists as aquaretic agents for the treatment of hyponatremia.
Topics: Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Humans; Hyponatremia; Inappropriate ADH Syndrome; Morpholines; Pyrroles; Randomized Controlled Trials as Topic; Spiro Compounds; Tolvaptan; Vasopressins | 2006 |
Therapeutic potential of vasopressin receptor antagonists.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Morpholines; Pyrroles; Receptors, Vasopressin; Spiro Compounds; Tolvaptan | 2007 |
[Vasopressin antagonists in treatment of hyponatremia].
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Heart Failure; Hormone Antagonists; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Sodium Chloride; Tolvaptan; Water-Electrolyte Balance | 2007 |
10 trial(s) available for tolvaptan and Inappropriate ADH Syndrome
| Article | Year |
|---|---|
Open-label, multicenter, dose-titration study to determine the efficacy and safety of tolvaptan in Japanese patients with hyponatremia secondary to syndrome of inappropriate secretion of antidiuretic hormone.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Japan; Male; Middle Aged; Tolvaptan; Treatment Outcome; Vasopressins; Young Adult | 2021 |
Low-dose tolvaptan PK/PD: comparison of patients with hyponatremia due to syndrome of inappropriate antidiuretic hormone secretion to healthy adults.
Topics: Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Creatinine; Cross-Over Studies; Double-Blind Method; Female; Healthy Volunteers; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Potassium; Sodium; Tolvaptan | 2017 |
A rapid and efficient way to manage hyponatremia in patients with SIADH and small cell lung cancer: treatment with tolvaptan.
Topics: Aged; Algorithms; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Lung Neoplasms; Male; Middle Aged; Small Cell Lung Carcinoma; Sodium; Tolvaptan | 2013 |
Randomized, double blinded, placebo-controlled trial to evaluate the efficacy and safety of tolvaptan in Chinese patients with hyponatremia caused by SIADH.
Topics: Adult; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Double-Blind Method; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Sodium; Tolvaptan; Treatment Outcome; Young Adult | 2014 |
Improving care and outcomes of inpatients with syndrome of inappropriate antidiuresis (SIAD): a prospective intervention study of intensive endocrine input vs. routine care.
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Demeclocycline; Female; Humans; Inappropriate ADH Syndrome; Male; Middle Aged; Prospective Studies; Retrospective Studies; Saline Solution, Hypertonic; Sodium; Tolvaptan; Treatment Outcome | 2017 |
Tolvaptan use in cancer patients with hyponatremia due to the syndrome of inappropriate antidiuretic hormone: a post hoc analysis of the SALT-1 and SALT-2 trials.
Topics: Administration, Oral; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Double-Blind Method; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Neoplasms; Sodium; Tolvaptan; Treatment Outcome | 2017 |
Efficacy and safety of oral tolvaptan therapy in patients with the syndrome of inappropriate antidiuretic hormone secretion.
Topics: Administration, Oral; Aged; Benzazepines; Dizziness; Double-Blind Method; Female; Follow-Up Studies; Humans; Inappropriate ADH Syndrome; Male; Middle Aged; Thirst; Tolvaptan; Treatment Outcome | 2011 |
High sensitivity to tolvaptan in paraneoplastic syndrome of inappropriate ADH secretion (SIADH).
Topics: Aged; Aged, 80 and over; Benzazepines; Female; Humans; Inappropriate ADH Syndrome; Lung Neoplasms; Male; Middle Aged; Natriuretic Agents; Paraneoplastic Endocrine Syndromes; Small Cell Lung Carcinoma; Tolvaptan; Treatment Outcome | 2011 |
Efficacy and tolerance of urea compared with vaptans for long-term treatment of patients with SIADH.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Morpholines; Sodium; Spiro Compounds; Time Factors; Tolvaptan; Urea | 2012 |
Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Area Under Curve; Benzazepines; Double-Blind Method; Female; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Male; Middle Aged; Sodium; Tolvaptan | 2006 |
75 other study(ies) available for tolvaptan and Inappropriate ADH Syndrome
| Article | Year |
|---|---|
Using Tolvaptan to Treat Hyponatremia: Results from a Post-authorization Pharmacovigilance Study.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Humans; Hyponatremia; Inappropriate ADH Syndrome; Pharmacovigilance; Prospective Studies; Sodium; Tolvaptan | 2021 |
[A case of SIADH due to pancreatic cancer was improved by tolvaptan].
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Humans; Inappropriate ADH Syndrome; Male; Pancreatic Neoplasms; Quality of Life; Tolvaptan; Vasopressins | 2022 |
[Hyponatraemia in elderly patient - significance, clarification and therapy].
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Humans; Hyponatremia; Inappropriate ADH Syndrome; Tolvaptan | 2022 |
Human herpesvirus 6 (HHV-6) associated permanent hyponatremia in umbilical cord blood transplant recipient.
Topics: Cord Blood Stem Cell Transplantation; Female; Foscarnet; Herpesvirus 6, Human; Humans; Hyponatremia; Inappropriate ADH Syndrome; Middle Aged; Roseolovirus Infections; Tolvaptan; Transplant Recipients; Viremia | 2023 |
Consensus document on the management of hyponatraemia of the Acqua Group of the Spanish Society of Endocrinology and Nutrition.
Topics: Consensus; Humans; Hyponatremia; Inappropriate ADH Syndrome; Saline Solution, Hypertonic; Tolvaptan | 2023 |
Tolvaptan resistance is related with a short-term poor prognosis in patients with lung cancer and syndrome of inappropriate anti-diuresis.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Humans; Hyponatremia; Inappropriate ADH Syndrome; Lung Neoplasms; Neoplasm Recurrence, Local; Prognosis; Tolvaptan | 2023 |
Syndrome of inappropriate secretion of anti-diuretic hormone due to hypothalamic hamartoma: use of tolvaptan.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuretics; Humans; Hyponatremia; Inappropriate ADH Syndrome; Seizures; Tolvaptan; Vasopressins | 2023 |
Relapsing Syndrome of Inappropriate Antidiuretic Hormone Production Responding to Tolvaptan Treatment in a Patient With a Micronodular Formation of the Posterior Pituitary Gland.
Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Pituitary Gland, Posterior; Tolvaptan; Vasopressins | 2023 |
Long-term low-dose tolvaptan efficacy and safety in SIADH.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Humans; Hyponatremia; Inappropriate ADH Syndrome; Retrospective Studies; Sodium; Tolvaptan | 2023 |
Effect of tolvaptan on hyponatremia in a dog with syndrome of inappropriate secretion of antidiuretic hormone.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Dog Diseases; Dogs; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Sodium; Tolvaptan; Vasopressins | 2023 |
A new method of intermittent lower dose of tolvaptan combined with fluid restriction to treat the syndrome of inappropriate antidiuresis: A case report.
Topics: Antidiuretic Hormone Receptor Antagonists; Combined Modality Therapy; Female; Fluid Therapy; Humans; Inappropriate ADH Syndrome; Middle Aged; Sodium; Tolvaptan; Treatment Outcome | 2019 |
Risk factors for sodium overcorrection in non-hypovolemic hyponatremia patients treated with tolvaptan.
Topics: Aged; Cohort Studies; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Retrospective Studies; Risk Factors; Sodium; Tolvaptan | 2020 |
[Hyponatremia in older persons (II)-A clear treatment : How to detect tricks and avoid pitfalls].
Topics: Aged; Aged, 80 and over; Algorithms; Antidiuretic Hormone Receptor Antagonists; Combined Modality Therapy; Fluid Therapy; Humans; Hyponatremia; Inappropriate ADH Syndrome; Infusions, Intravenous; Saline Solution, Hypertonic; Tolvaptan; Treatment Outcome | 2020 |
Tolvaptan treatment in hyponatremia due to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH): effects on survival in patients with cancer.
Topics: Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Neoplasms; Retrospective Studies; Survival Rate; Tolvaptan | 2021 |
Syndrome of inappropriate antidiuretic hormone release as the initial presentation of adenocarcinoma of the colon.
Topics: Adenocarcinoma; Colon; Humans; Inappropriate ADH Syndrome; Male; Middle Aged; Tolvaptan; Vasopressins | 2020 |
Real-World, Non-Interventional, Retrospective Study (SAMPLE) of Tolvaptan in Patients with Hyponatraemia Secondary to the Syndrome of Inappropriate Antidiuretic Hormone Secretion.
Topics: Adult; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Germany; Humans; Hyponatremia; Inappropriate ADH Syndrome; Retrospective Studies; Spain; Tolvaptan; Vasopressins | 2021 |
The V2 receptor antagonist tolvaptan raises cytosolic calcium and prevents AQP2 trafficking and function: an in vitro and in vivo assessment.
Topics: Aged, 80 and over; Animals; Antidiuretic Hormone Receptor Antagonists; Aquaporin 2; Benzazepines; Calcium; Cell Membrane; Cell Membrane Permeability; Cyclic AMP; Cytosol; Dogs; Endoplasmic Reticulum; Female; Fluorescence Resonance Energy Transfer; Humans; Inappropriate ADH Syndrome; Kidney; Madin Darby Canine Kidney Cells; Male; Mice, Knockout; Middle Aged; Osmosis; Phosphorylation; Protein Phosphatase 1; Protein Transport; Receptors, Vasopressin; Sodium; Tolvaptan; Water | 2017 |
An economic analysis of tolvaptan compared with fluid restriction among hospitalized patients with hyponatremia.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Decision Support Techniques; Fluid Therapy; Heart Failure; Hospitalization; Humans; Hyponatremia; Inappropriate ADH Syndrome; Intensive Care Units; Length of Stay; Models, Econometric; Patient Readmission; Severity of Illness Index; Sodium; Tolvaptan | 2017 |
Pure small cell recurrent prostate cancer developing syndrome of inappropriate antidiuretic hormone secretion.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Brachytherapy; Carcinoma, Small Cell; Humans; Inappropriate ADH Syndrome; Male; Neoplasm Recurrence, Local; Prostatic Neoplasms; Syndrome; Tolvaptan | 2017 |
Secondary resistance to tolvaptan in two patients with SIAD due to small cell lung cancer.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Drug Resistance; Fatal Outcome; Female; Genetic Diseases, X-Linked; Humans; Inappropriate ADH Syndrome; Lung Neoplasms; Male; Middle Aged; Small Cell Lung Carcinoma; Sodium; Tolvaptan; Vasopressins | 2018 |
Amiodarone-Induced Hyponatremia Masked by Tolvaptan in a Patient with an Implantable Left Ventricular Assist Device.
Topics: Adult; Amiodarone; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Delirium; Heart Failure; Heart-Assist Devices; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Sodium Channel Blockers; Tolvaptan | 2017 |
Rapidity of Correction of Hyponatremia Due to Syndrome of Inappropriate Secretion of Antidiuretic Hormone Following Tolvaptan.
Topics: Adult; Aged; Antidiuretic Hormone Receptor Antagonists; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Linear Models; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Severity of Illness Index; Sodium; Tolvaptan; Treatment Outcome | 2018 |
Safety and Efficacy of Tolvaptan in Korean Patients with Hyponatremia Caused by the Syndrome of Inappropriate Antidiuretic Hormone.
Topics: Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Asian People; Benzazepines; Body Mass Index; Body Weight; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Republic of Korea; Sodium; Tolvaptan; Treatment Outcome; Young Adult | 2018 |
Tolvaptan for the Syndrome of Inappropriate Secretion of Antidiuretic Hormone: Is the Dose Too High?
Topics: Antidiuretic Hormone Receptor Antagonists; Humans; Hyponatremia; Inappropriate ADH Syndrome; Tolvaptan; Vasopressins | 2018 |
SIADH with Severe Hyponatremia in an Elderly Man with Herpes Zoster Infection: A Causal or Casual Association?
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Herpes Zoster; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Saline Solution, Hypertonic; Tolvaptan | 2018 |
Efficiency of Single Dose of Tolvaptan Treatment During the Triphasic Episode After Surgery for Craniopharyngioma
Topics: Adolescent; Antidiuretic Hormone Receptor Antagonists; Craniopharyngioma; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Neurosurgical Procedures; Pituitary Neoplasms; Postoperative Complications; Prognosis; Tolvaptan | 2019 |
Tolvaptan corrects hyponatremia and relieves the burden of fluid/dietary restriction and hospitalization in hyponatremic patients with terminal lung cancer: a report of two cases.
Topics: Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Hospitalization; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Patient Discharge; Quality of Life; Small Cell Lung Carcinoma; Tolvaptan; Treatment Outcome | 2019 |
Syndrome of inadequate antidiuretic hormone secretion in pulmonary tuberculosis - a therapeutic challenge.
Topics: Antibiotics, Antitubercular; Benzazepines; Combined Modality Therapy; Diet, Sodium-Restricted; Drug Interactions; Female; Fluid Therapy; Humans; Inappropriate ADH Syndrome; Middle Aged; Rifampin; Syndrome; Tolvaptan; Treatment Failure; Tuberculosis, Pulmonary | 2013 |
Juxtaglomerular cell tumor: multicentric synchronous disease associated with paraneoplastic syndrome.
Topics: Antidiuretic Hormone Receptor Antagonists; Antineoplastic Combined Chemotherapy Protocols; Benzazepines; Dacarbazine; Deoxycytidine; Diagnosis, Differential; Disease Progression; Doxorubicin; Gemcitabine; Humans; Hyponatremia; Ifosfamide; Immunohistochemistry; Immunophenotyping; Inappropriate ADH Syndrome; Juxtaglomerular Apparatus; Kidney Neoplasms; Luminescent Measurements; Male; Middle Aged; Neoplasms, Multiple Primary; Paclitaxel; Paraneoplastic Syndromes; Renin; Tolvaptan; Vinblastine; Vinorelbine | 2013 |
[Severe hyponatremia secondary to the syndrome of inappropriate secretion of antidiuretic hormone].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Brain Injuries; Confusion; Humans; Hyponatremia; Inappropriate ADH Syndrome; Kidney; Male; Middle Aged; Multiple Trauma; Paraventricular Hypothalamic Nucleus; Psychomotor Agitation; Rhabdomyolysis; Saline Solution, Hypertonic; Supraoptic Nucleus; Tolvaptan | 2013 |
Factors predicting postoperative hyponatremia and efficacy of hyponatremia management strategies after more than 1000 pituitary operations.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Child; Child, Preschool; Female; Humans; Hyponatremia; Hypopituitarism; Inappropriate ADH Syndrome; Male; Middle Aged; Neurosurgical Procedures; Pituitary Gland; Postoperative Complications; Retrospective Studies; Sodium; Tolvaptan; Treatment Outcome; Young Adult | 2013 |
[The treament of hyponatremia secundary to the syndrome of inappropriate antidiuretic hormone secretion].
Topics: Acute Disease; Algorithms; Benzazepines; Combined Modality Therapy; Decision Support Techniques; Fluid Therapy; Furosemide; Humans; Hyponatremia; Inappropriate ADH Syndrome; Infusions, Intravenous; Saline Solution, Hypertonic; Severity of Illness Index; Tolvaptan | 2013 |
Prompt efficacy of tolvaptan in treating hyponatremia of syndrome of inappropriate secretion of antidiuretic hormone (SIADH) closely associated with rupture of a gastric artery aneurysm.
Topics: Abdominal Pain; Aged; Aneurysm; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Brain; Humans; Hyponatremia; Inappropriate ADH Syndrome; Magnetic Resonance Imaging; Male; Osmolar Concentration; Stomach; Tolvaptan | 2014 |
Tolvaptan treatment of severe stroke-like symptoms and bilateral subcortical diffusion restriction due to syndrome of inappropriate secretion of ADH after polytrauma.
Topics: Adolescent; Angiography; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diffusion Magnetic Resonance Imaging; Humans; Inappropriate ADH Syndrome; Male; Multiple Trauma; Stroke; Time Factors; Tolvaptan; Tomography Scanners, X-Ray Computed | 2014 |
Treatment of hyponatremia induced by the syndrome of Inappropriate antidiuretic hormone secretion: a multidisciplinary spanish algorithm.
Topics: Algorithms; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Humans; Hyponatremia; Inappropriate ADH Syndrome; Saline Solution, Hypertonic; Tolvaptan | 2014 |
Once-weekly tolvaptan for chronic symptomatic hyponatremia due to syndrome of inappropriate secretion of anti-diuretic hormone.
Topics: Aged, 80 and over; Benzazepines; Chronic Disease; Drug Administration Schedule; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Tolvaptan | 2014 |
[Treatment with urea as an alternative to tolvaptan for the syndrome of inappropriate secretion of antidiuretic hormone].
Topics: Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Female; Humans; Inappropriate ADH Syndrome; Tolvaptan; Urea | 2014 |
[Symptomatic therapy of SIADH in small cell lung cancer by tolvaptan].
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Female; Humans; Inappropriate ADH Syndrome; Lung Neoplasms; Paraneoplastic Syndromes; Small Cell Lung Carcinoma; Tolvaptan; Treatment Outcome | 2014 |
[Hyponatremia: differential diagnosis and therapy].
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diagnosis, Differential; Evidence-Based Medicine; Fluid Therapy; Humans; Hyponatremia; Inappropriate ADH Syndrome; Tolvaptan | 2014 |
[Lower doses of tolvaptan in hyponatremia due to syndrome of inappropriate antidiuretic hormone secretion].
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Tolvaptan; Treatment Outcome | 2015 |
Efficacy and safety of long-term tolvaptan treatment in a patient with SCLC and SIADH.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Chemoradiotherapy; Drug Administration Schedule; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Lung Neoplasms; Middle Aged; Remission Induction; Small Cell Lung Carcinoma; Tolvaptan; Treatment Outcome | 2015 |
[Syndrome of inadequate ADH secretion: pitfalls in diagnosis and therapy].
Topics: Aged; Benzazepines; Female; Humans; Hyperkalemia; Hyponatremia; Inappropriate ADH Syndrome; Long-Term Care; Male; Middle Aged; Prognosis; Saline Solution, Hypertonic; Sodium; Tolvaptan; Water Deprivation | 2015 |
The first case of levetiracetam-induced and tolvaptan-resistant hyponatremia.
Topics: Aged; Anticonvulsants; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Epilepsy; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Levetiracetam; Male; Piracetam; Tolvaptan | 2015 |
The diagnosis and management of inpatient hyponatraemia and SIADH.
Topics: Algorithms; Anti-Bacterial Agents; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Demeclocycline; Fluid Therapy; Hospitalization; Humans; Hyponatremia; Inappropriate ADH Syndrome; Practice Guidelines as Topic; Tolvaptan; Water-Electrolyte Imbalance | 2015 |
[77-year-old female with hyponatremia, pruritus and papulous exanthema].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Benzazepines; Diagnosis, Differential; Disease Progression; Exanthema; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Lymphoma, T-Cell, Cutaneous; Multimodal Imaging; Paraneoplastic Syndromes; Positron-Emission Tomography; Pruritus; Tolvaptan; Tomography, X-Ray Computed | 2015 |
Mutation in the V2 vasopressin receptor gene, AVPR2, causes nephrogenic syndrome of inappropriate diuresis.
Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Arrestins; Benzazepines; beta-Arrestins; Cell Membrane; Cyclic AMP; DNA Mutational Analysis; Dynamins; Endocytosis; Exons; Female; Genetic Diseases, X-Linked; HEK293 Cells; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Mutation; Pedigree; Receptors, Vasopressin; Tolvaptan | 2015 |
'Dos and don'ts' in the management of hyponatremia.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Disease Management; Fluid Therapy; Humans; Hyponatremia; Inappropriate ADH Syndrome; Practice Guidelines as Topic; Saline Solution, Hypertonic; Tolvaptan; Water-Electrolyte Balance | 2015 |
Real-life experience of tolvaptan use in the treatment of severe hyponatraemia due to syndrome of inappropriate antidiuretic hormone secretion.
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Humans; Hyponatremia; Inappropriate ADH Syndrome; Inpatients; Length of Stay; Middle Aged; Retrospective Studies; Severity of Illness Index; Sodium; Time Factors; Tolvaptan; Treatment Outcome | 2016 |
SIADH-related hyponatremia in hospital day care units: clinical experience and management with tolvaptan.
Topics: Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Day Care, Medical; Female; Hospitalization; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Quality of Life; Retrospective Studies; Tolvaptan | 2016 |
Tolvaptan for SIADH in Myelodysplastic Syndrome with Blast Crisis.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blast Crisis; Female; Humans; Inappropriate ADH Syndrome; Myelodysplastic Syndromes; Tolvaptan | 2015 |
Low-dose tolvaptan for the treatment of hyponatremia in the syndrome of inappropriate ADH secretion (SIADH).
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Tolvaptan; Treatment Outcome | 2016 |
Tolvaptan is successful in treating inappropriate antidiuretic hormone secretion in infants.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Female; Humans; Inappropriate ADH Syndrome; Infant, Newborn; Male; Retrospective Studies; Tolvaptan | 2016 |
Cost-effectiveness of tolvaptan for the treatment of hyponatraemia secondary to syndrome of inappropriate antidiuretic hormone secretion in Sweden.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cost-Benefit Analysis; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Lung Neoplasms; Male; Pneumonia; Quality-Adjusted Life Years; Sweden; Tolvaptan | 2016 |
Urea is successful in treating inappropriate antidiuretic hormone secretion in an infant.
Topics: Antidiuretic Hormone Receptor Antagonists; Humans; Inappropriate ADH Syndrome; Infant; Male; Tolvaptan; Urea | 2017 |
Effect of single-dose of tolvaptan in neurocritical patients with hyponatremia due to syndrome of inappropriate antidiuretic hormone secretion.
Topics: Adult; Benzazepines; Brain Injuries, Traumatic; Cerebral Hemorrhage; Critical Care; Critical Illness; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Retrospective Studies; Sodium; Subarachnoid Hemorrhage; Tolvaptan; Water-Electrolyte Balance | 2017 |
[Current options of treatment of hyponatremia].
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Europe; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Receptors, Vasopressin; Sodium; Tolvaptan; Vasopressins | 2016 |
Comparison of tolvaptan treatment between patients with the SIADH and congestive heart failure: a single-center experience.
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Female; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Retrospective Studies; Tolvaptan | 2018 |
Tolvaptan: any evidence of efficacy in SIADH?
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Clinical Trials as Topic; Heart Failure; Humans; Inappropriate ADH Syndrome; Off-Label Use; Sodium; Tolvaptan | 2010 |
[Tolvaptan in antidiuretic hormone secretion syndrome secondary to treatment with citalopram].
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Citalopram; Humans; Inappropriate ADH Syndrome; Male; Selective Serotonin Reuptake Inhibitors; Tolvaptan | 2011 |
Serum and urine responses to the aquaretic agent tolvaptan in hospitalized hyponatremic patients.
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Blood Pressure; Diuretics; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Osmolar Concentration; Sodium; Tolvaptan | 2012 |
Tolvaptan.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Humans; Hyponatremia; Inappropriate ADH Syndrome; Tolvaptan | 2012 |
Syndrome of inappropriate secretion of antidiuretic hormone in traumatic brain injury: when tolvaptan becomes a life saving drug.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Brain Injuries; Humans; Inappropriate ADH Syndrome; Male; Meningoencephalitis; Middle Aged; Tolvaptan | 2012 |
Evaluation of costs associated with tolvaptan-mediated hospital length of stay reduction among US patients with the syndrome of inappropriate antidiuretic hormone secretion, based on SALT-1 and SALT-2 trials.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Benzazepines; Cost Savings; Female; Health Care Costs; Hospitalization; Humans; Hyponatremia; Inappropriate ADH Syndrome; Length of Stay; Male; Middle Aged; Monte Carlo Method; Randomized Controlled Trials as Topic; Tolvaptan; United States; Young Adult | 2012 |
Considerations regarding the management of hyponatraemia secondary to SIADH.
Topics: Aged; Benzazepines; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Osmolar Concentration; Saline Solution, Hypertonic; Time Factors; Tolvaptan; Treatment Outcome; Water | 2012 |
Perspectives on the management of hyponatraemia secondary to SIADH across Europe.
Topics: Antidiuretic Hormone Receptor Antagonists; Awareness; Benzazepines; Costs and Cost Analysis; Education, Medical; Europe; Humans; Hyponatremia; Inappropriate ADH Syndrome; Osmolar Concentration; Prognosis; Surveys and Questionnaires; Tolvaptan; Urine | 2012 |
[Diagnostics and new treatment methods of syndrome of inappropriate antidiuretic hormone secretion (SIADH)].
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diagnosis, Differential; Humans; Inappropriate ADH Syndrome; Prognosis; Sodium Chloride; Tolvaptan; Urea; Water-Electrolyte Balance | 2012 |
What is the role of vaptans in routine clinical nephrology?
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Female; Humans; Inappropriate ADH Syndrome; Male; Morpholines; Spiro Compounds; Tolvaptan; Urea | 2012 |
[A case of venlafaxine-induced syndrome of inappropriate ADH secretion (SIADH) - treatment with tolvaptan].
Topics: Aged; Antidepressive Agents, Second-Generation; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cyclohexanols; Depressive Disorder; Diagnosis, Differential; Epilepsy, Generalized; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Tolvaptan; Venlafaxine Hydrochloride | 2012 |
[SIADH - a "shambles"].
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Humans; Inappropriate ADH Syndrome; Tolvaptan | 2012 |
Vasopressin receptor antagonist in the treatment of the syndrome of inappropriate antidiuretic hormone in general hospital practice.
Topics: Adult; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Female; Hormone Antagonists; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Retrospective Studies; Sodium; Tolvaptan; United Kingdom | 2012 |
[Vasopressin antagonist in hyponatremia. Rapid and simple control of serum sodium concentration].
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Controlled Clinical Trials as Topic; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Sodium; Tolvaptan | 2012 |
Nephrogenic syndrome of inappropriate antidiuresis in adults: high phenotypic variability in men and women from a large pedigree.
Topics: Adult; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Brain; Child; Clinical Trials as Topic; Female; Genetic Variation; Humans; Inappropriate ADH Syndrome; Male; Pedigree; Phenotype; Receptors, Vasopressin; Tolvaptan | 2007 |
Tolvaptan for hyponatremia.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Patient Dropouts; Tolvaptan; Water-Electrolyte Balance | 2007 |
Tolvaptan for hyponatremia.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Volume; Humans; Hyponatremia; Hypovolemia; Inappropriate ADH Syndrome; Tolvaptan | 2007 |
Tolvaptan for hyponatremia.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Volume; Diuretics; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Tolvaptan | 2007 |